Scheduled maintenance This site will be offline from 13:30 to 15:00 CEST on Monday, 21 October 2024 in order to be moved to a new infrastructure. We apologise for the inconvenience. Please check the Slack channel #dc-system-status for updates. The development team can be contacted at datacentre@scilifelab.se if you have any question.

J Biomol Struct Dyn

JSON

ISSN	1538-0254
ISSN-L	-
IUID	97825df3b18442af822e3de04a8070dd
Modified	2022-02-11T10:24:41.341Z
Created	2022-02-11T10:24:41.341Z

Year 2022

PubMed DOI Crossref

Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies.

Giron CC, Laaksonen A, Barroso da Silva FL

J Biomol Struct Dyn - (-) 1-21 [2022-07-09; online 2022-07-09]

Category: Biochemistry Category: Health Category: Omicron VoC Type: Journal article

PubMed DOI Crossref

Whole genome analysis and homology modeling of SARS-CoV-2 Indian isolate reveals potent FDA approved drug choice for treating COVID-19.

Velu P, Rathinavel T, Kumarasamy S, ..., Rajamanickam K, Shanmugam G

J Biomol Struct Dyn - (-) 1-17 [2022-02-09; online 2022-02-09]

Category: Genomics & transcriptomics Category: Health Category: Public Health Type: Journal article

SciLifeLab Data Centre

Publications 9.5.1-pretest